Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study) [version 1; referees: 2 approved]

Background: In vitro, animal, biological and observational clinical studies suggest that some hormonal methods, particularly depot medroxyprogesterone acetate – DMPA, may increase women’s risk of HIV acquisition. DMPA is the most common contraceptive used in many countries worst affected by the HIV...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: G. Justus Hofmeyr, Charles S. Morrison, Jared M. Baeten, Tsungai Chipato, Deborah Donnell, Peter Gichangi, Nelly Mugo, Kavita Nanda, Helen Rees, Petrus Steyn, Douglas Taylor, ECHO Trial Team
Médium: Artigo
Jazyk:Inglês
Vydáno: F1000 Research Ltd 2017-12-01
Edice:Gates Open Research
On-line přístup:https://gatesopenresearch.org/articles/1-17/v1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky